Recursion Pharmaceuticals
The AI engine Fit Assessment
BetaRecursion leverages machine learning to discover new biological patterns and expand therapeutic options, including drug repurposing.
Blurb
Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.
HQ Location
United States
Founded
2013
Employees
501 - 1000
Total funding raised
$3.78B
Last Funding Event
Post-IPO Equity, $200.00M, June 26, 2024
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Drug Repurposing
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.